GlaxoSmithKline (GSK)

44.28 +0.04  +0.09%  May 25, 11:00PM Go Pro
You must be signed in to use watchlists.
Sign In or Register
Watch this stock

GlaxoSmithKline Price / Sales Ratio: 2.542

Get Interactive Chart for


of


Select a metric
 
Date range: to
<Embed Chart> Pro Save as Image Pro Data Export
Copy the code below and paste
into the embed destination.
  Done
Attention OK

GSK Price / Sales Ratio Rankings

Overall 24th percentile 3269 of 4332
Sector 48th percentile 233 of 450 in Healthcare
Industry 26th percentile 14 of 19 in Drug Manufacturers - Major

GSK Price / Sales Ratio Range, Past 5 Years

Minimum 1.870 Mar 2009
Maximum 3.284 Jun 2007
Average 2.499

About Price to Sales Ratio

The price to sales ratio (PS ratio) is calculated by dividing stock price by the revenue per share. It is most useful for comparing companies within a sector or industry because "normal" values for this ratio vary from industry to industry. In general, low price to sales ratios are more appealing because they suggest that a company is undervalued.

An example illustrating why PS ratios should not be compared across industries: On June 21, 2010, Starbucks had a PS ratio of 1.12 while Yahoo! had a PS ratio of 2.56. In other words, Yahoo! shareholders were paying $2.56 for $1 of sales while Starbucks shareholders would only pay $1.12 for $1 of sales. However, at that same moment, the two companies' price to earnings ratios were virtually identical (Starbucks: 28.09 and Yahoo!: 27.78). Hence, shareholders were paying nearly the same amount for $1.00 in earnings. The PS ratios, though, are less comparable since Yahoo!'s profit margins are much higher than that of Starbucks.
Learn More

You may also be interested in these GSK related companies

Display in Live Stream: Done
Options

GSK News

4 Stocks Buffett May Be Buying in Europe
May 25, 12:21PM Investor Place
Finding a Pathway to Approval
May 24, 2:53PM Fool
$GSK reacts to $HGSI poison pill. Stubborn, or what? It seems they do not want to get pushed or pulled.
about 3 days ago by OysterX
20 Giants for a 6% Dividend Yield
May 21, 9:07AM Fool
@xjun &quot;totally betrayed&quot; $AMRN says: &quot;Sorry, it&#39;s not personal. Look at some of my neighbours: $ONTY, $SPPI, $NVAX, $GSK, $TEVA, $CELG ...&quot;
about 8 days ago by mitrado
Why U.K. Bonds Are for Losers
May 17, 6:07PM Fool
Still think that $GSK will not succeed with $HGSI takeover at 13/share. They will increase the offer price, but probably not above 15.
about 9 days ago by OysterX
News related to $GSK, currently 0.0% since open: &#39;Prestige Brands posts small fiscal 4Q loss&#39; http://stks.co/3s9V
about 9 days ago by TradeBot
Gilead Sciences’ HIV Drugs Clear a Hurdle
May 17, 10:00AM Investor Place
$GSK Trametinib also in the spotlight at ASCO &#39;12 with six presentations over 4 days. http://stks.co/3roL
about 9 days ago by abubnic
$GSK Dabrafenib getting its share of attention at ASCO &#39;12 with 50 presentations over 4 days. http://stks.co/3roI
about 9 days ago by abubnic
$PFE $LLY $GSK So this is the condition some drug commercials warned us about! And we thought they were kidding. http://stks.co/3q2n
about 11 days ago by laughing_stock
Don&#39;t see $XNPT popping 100% like $ARNA did, not as glamorous and still has to settle with $GSK. They would get 10 million if still partnrd
about 11 days ago by Glopolon
5 Dividends to Reinvest
May 14, 10:34AM Fool
$ARNA -Big brand name companies may be interested in buyout $GSK $PFE $SNY $ABT First weight-loss drug in US may be approved in June $SPY $$
about 13 days ago by peterumble
$XNPT, No Debt, Drug has already been approved for RLS, so safety issues known. Court case with $GSK still out there, want settlement.
about 15 days ago by Glopolon
Some really tempting European stocks that pay healthy dividends $SNY $HBC $SI $ABB $SNY $GSK $RDS.B all above 4%
about 17 days ago by sld1986
$VVUS Racked With Losses, Vivus is Putting All Its Eggs in This Basket http://stks.co/3kNz $OREX $ARNA $PFE $LLY $GSK
about 17 days ago by DrNick
RT @JasonMilano8 $AMRN Here is a news about current CEO of Amarin selling his former company Reliant to ($GSK) in 2007: http://stks.co/3k0G
about 17 days ago by JasonMilano8
Breakfast Links | via @PointsnFigures http://stks.co/3jto $AMZN $GSK $HGSI $ZNGA
about 17 days ago by STNet
That&#39;s a surprise. $GSK goes hostile with $HGSI offer at 13. Did not expect that and am curious whether HGSI has something up its sleeve.
about 17 days ago by OysterX
$AMRN Here is a news about current CEO of Amarin selling his former company Reliant to GlaxoSmithKline ($GSK) in 2007: http://stks.co/3jYt
about 17 days ago by JasonMilano8
$XNPT, Only non-dopaminergic option for RLS, is the advantage over generics. If $XNPT can work things out with $GSK, this should be $5+
about 18 days ago by Glopolon
Huf Post: Two Drugs Harness Immune System To Fight Cancer. http://stks.co/3iDa $DNDN $BMY $AZN $ONTY $GSK
about 18 days ago by abubnic
@BioRunUp @GantosJ $XNPT, Hope that they can settle w/ $GSK, and if Astellas in Japan is competent, then $XNPT is looking good.
about 19 days ago by Glopolon
$XNPT Sounds like Astellas is going to be better partner than $GSK, Hope they can work things out with $GSK re: Horizant.
about 20 days ago by Glopolon
$XNPT $GSK, FDA PDUFA date June 9th for Horizant treating postherpetic neuralgia. Horizant already approved in Japan for restless leg synd.
about 22 days ago by Glopolon
Best Yielding Large Cap Healthcare Stocks + http://stks.co/3cMJ + $JNJ $PFE $NVS $MRK $GSK $SNY $NVO $UNH $BMY $TEVA $MDT $BAX $AGN $SYK
about 24 days ago by DividendYield
@WolfpackInvest I never hold long through PDUFA but I&#39;m making an exception for $AMRN. Dont sell your position unles $PHE or $GSK are buying
about 25 days ago by junkmailman
$AMRN i still think GlaxoSmithKline ($GSK) will grab Amarin $AMRN around $20. We should see $AMRN here soon: http://stks.co/3aOF
about 26 days ago by JasonMilano8

Recent Quotes

Symbol Price Chg Chg % Market Cap
GSK 44.28 +0.04 +0.09% 111.75B
GSIT 4.20 +0.00 +0.00% 120.25M
GSB 2.15 +0.03 +1.42% 39.15M
GSAT 0.4049 +0.03 +6.58% 120.61M
GS 96.70 -0.16 -0.17% 47.86B
GRZ 3.29 +0.07 +2.17% 195.89M
GRRF 3.11 +0.00 +0.00% 70.69M
GRO 1.07 +0.00 +0.00% 59.26M
GRMN 43.19 -0.53 -1.21% 8.406B
GRA 52.56 -1.03 -1.92% 3.886B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close